Results 81 to 90 of about 106 (91)

ADAM gene expression and regulation during human osteoclast formation

Bone, 2004
Sophie Verrier, A Hogan
exaly  

Synthesis and comparison of 4-[18F]F-ADAM, 2-[18F]F-ADAM, N-Desmethyl-4-[18F]F-ADAM and [18F]F-AFM as serotonin transporter imaging agents

Applied Radiation and Isotopes, 2012
Ya-Yao Huang, Wen-Sheng Huang, Ta-Kai Chou   +2 more
exaly  

siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line

Neuroscience Letters, 2012
Basil Sharrack, M Nicola Woodroofe
exaly  

Molecular implication of ADAM-15 and 17 in intrauterine adhesions

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2013
Dan Liu, Xueyu Zhang, Peishu Liu
exaly  

ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin

FEBS Letters, 2013
Daniel W Lambert, Paul M Speight, Simon A Whawell   +2 more
exaly  

Salt-Mediated Nanopore Detection of ADAM-17

ACS Applied Bio Materials, 2019
Xiaohan Chen, Youwen Zhang, Xiyun Guan   +2 more
exaly  

Trafficking of Human ADAM 12-L: Retention in the trans-Golgi Network

Biochemical and Biophysical Research Communications, 2000
Frosty Loechel, Reidar Albrechtsen, Ulla M Wewer   +2 more
exaly  

Increased expression of ADAM family members in human breast cancer and breast cancer cell lines

Journal of Cancer Research and Clinical Oncology, 2004
Uwe Lendeckel, Stacy Carl-Mcgrath, Christoph Röcken   +2 more
exaly  

Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models

European Journal of Medicinal Chemistry, 2016
Caterina Camodeca, Elisa Nuti, Livia Tepshi   +2 more
exaly  

Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis

Bioorganic and Medicinal Chemistry Letters, 2011
Chris De Savi, John G Cumming, Scott Lamont   +2 more
exaly